Vol 9, No 4 (2024)
Review article
Published online: 2024-12-23

open access

Page views 41
Article views/downloads 20
Get Citation

Connect on Social Media

Connect on Social Media

Oncological outcomes, safety, efficacy in high BMI patients, attitude, and cost of robotic surgery for endometrial cancer management: a systematic review

Franciszek Ługowski1, Julia Babińska1
DOI: 10.5603/mrj.101793
Med Res J 2024;9(4):431-438.

Abstract

Introduction: Endometrial cancer is one of the most widespread gynecological carcinomas, and its incidence
is constantly increasing. Numerous non-genetic factors play a role in its development. Therefore,
many patients present with major comorbidities. Robotic surgery is becoming a well-established method of
endometrial cancer surgical management. It is considered especially beneficial in vulnerable populations,
such as high BMI patients.

Material and methods: A systematic literature search was performed in the Web of Science, PubMed, and
Scopus databases. The review was conducted following the Preferred Reporting Items for Systematic
Reviews and Meta-Analyses (PRISMA) guidelines.

Results: We screened 1135 articles altogether, with 19 studies included in the analysis. Robotic surgery
is currently considered as effective and as safe as laparoscopic surgery and safer than open surgery. It
correlates with fewer perioperative complications, lower blood loss, and longer operating time. Cost and
public awareness remain major issues regarding robotic surgery. Therefore, educational interventions
could be beneficial in raising awareness of this method of endometrial cancer management.

Article available in PDF format

View PDF Download PDF file

References

  1. Blair AR, Casas CM. Gynecologic cancers. Prim Care. 2009; 36(1): 115–30, ix.
  2. Bendifallah S, Ballester M, Daraï E. [Endometrial cancer: Predictive models and clinical impact]. Bull Cancer. 2017; 104(12): 1022–1031.
  3. Amant F, Moerman P, Neven P, et al. Endometrial cancer. The Lancet. 2005; 366(9484): 491–505.
  4. Siegel R, Miller K, Wagle N, et al. Cancer statistics, 2023. CA: A Cancer Journal for Clinicians. 2023; 73(1): 17–48.
  5. Yancik R. Population aging and cancer: a cross-national concern. Cancer J. 2005; 11(6): 437–441.
  6. Raglan O, Kalliala I, Markozannes G, et al. Risk factors for endometrial cancer: An umbrella review of the literature. Int J Cancer. 2019; 145(7): 1719–1730.
  7. Kitson S, Crosbie E. Endometrial cancer and obesity. The Obstetrician & Gynaecologist. 2019; 21(4): 237–245.
  8. Lau S, Buzaglo K, Vaknin Z, et al. Relationship between body mass index and robotic surgery outcomes of women diagnosed with endometrial cancer. Int J Gynecol Cancer. 2011; 21(4): 722–729.
  9. Giugale LE, Di Santo N, Smolkin ME, et al. Beyond mere obesity: effect of increasing obesity classifications on hysterectomy outcomes for uterine cancer/hyperplasia. Gynecol Oncol. 2012; 127(2): 326–331.
  10. Bouwman F, Smits A, Lopes A, et al. The impact of BMI on surgical complications and outcomes in endometrial cancer surgery--an institutional study and systematic review of the literature. Gynecol Oncol. 2015; 139(2): 369–376.
  11. Lamvu G, Zolnoun D, Boggess J, et al. Obesity: physiologic changes and challenges during laparoscopy. Am J Obstet Gynecol. 2004; 191(2): 669–674.
  12. Colombo, N., Creutzberg, C. Amant, F., Bosse, T., González-Martín, A., Ledermann, J., ... & Mirza, M. R. ESMO-ESGO-ESTRO Consensus Conference on Endometrial Cancer: Diagnosis, treatment and. ; 2016.
  13. Rungruang B, Olawaiye AB. Comprehensive surgical staging for endometrial cancer. Rev Obstet Gynecol. 2012; 5(1): 28–34.
  14. Berek JS, Matias-Guiu X, Creutzberg C, et al. Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. FIGO staging of endometrial cancer: 2023. J Gynecol Oncol. 2023; 34(5): e85.
  15. Morrow CP, Bundy BN, Kurman RJ, et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol Oncol. 1991; 40(1): 55–65.
  16. Rossi EC, Kowalski LD, Scalici J, et al. A comparison of sentinel lymph node biopsy to lymphadenectomy for endometrial cancer staging (FIRES trial): a multicentre, prospective, cohort study. Lancet Oncol. 2017; 18(3): 384–392.
  17. Tanaka T, Terai Y, Ashihara K, et al. The detection of sentinel lymph nodes in laparoscopic surgery for uterine cervical cancer using 99m-technetium-tin colloid, indocyanine green, and blue dye. J Gynecol Oncol. 2017; 28(2): e13.
  18. Walker J, Piedmonte M, Spirtos N, et al. Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2. Obstetrical & Gynecological Survey. 2010; 65(8): 503–505.
  19. Markowska A, Baranowski W, Pityński K, et al. Metastases and Recurrence Risk Factors in Endometrial Cancer-The Role of Selected Molecular Changes, Hormonal Factors, Diagnostic Methods and Surgery Procedures. Cancers (Basel). 2023; 16(1).
  20. Collins A, Jacob A, Moss E. Robotic-assisted surgery in high-risk surgical patients with endometrial cancer. Best Pract Res Clin Obstet Gynaecol. 2024; 92: 102421.
  21. Concin N, Matias-Guiu X, Vergote I, et al. ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma. Int J Gynecol Cancer. 2021; 31(1): 12–39.
  22. Papadia A, Imboden S, Siegenthaler F, et al. Laparoscopic Indocyanine Green Sentinel Lymph Node Mapping in Endometrial Cancer. Ann Surg Oncol. 2016; 23(7): 2206–2211.
  23. Chopra H, Baig AA, Cavalu S, et al. Robotics in surgery: Current trends. Ann Med Surg (Lond). 2022; 81: 104375.
  24. Raffone A, Travaglino A, Raimondo D, et al. Laparotomic versus robotic surgery in elderly patients with endometrial cancer: A systematic review and meta-analysis. Int J Gynaecol Obstet. 2022; 157(1): 1–10.
  25. Advincula AP, Falcone T. Laparoscopic robotic gynecologic surgery. Obstet Gynecol Clin North Am. 2004; 31(3): 599–609, ix.
  26. Moon AS, Garofalo J, Koirala P, et al. Robotic Surgery in Gynecology. Surg Clin North Am. 2020; 100(2): 445–460.
  27. Ballester M, Bendifallah S, Daraï E. [European guidelines (ESMO-ESGO-ESTRO consensus conference) for the management of endometrial cancer]. Bull Cancer. 2017; 104(12): 1032–1038.
  28. Ind TEJ, Marshall C, Hacking M, et al. Introducing robotic surgery into an endometrial cancer service--a prospective evaluation of clinical and economic outcomes in a UK institution. Int J Med Robot. 2016; 12(1): 137–144.
  29. Randell R, Alvarado N, Honey S, et al. Impact of Robotic Surgery on Decision Making: Perspectives of Surgical Teams. AMIA Annu Symp Proc. 2015; 2015: 1057–1066.
  30. Corrado G, Vizza E, Perrone AM, et al. Comparison Between Laparoscopic and Robotic Surgery in Elderly Patients With Endometrial Cancer: A Retrospective Multicentric Study. Front Oncol. 2021; 11: 724886.
  31. Yoon JH, Yun CY, Choi S, et al. Is robotic surgery beneficial for the treatment of endometrial cancer? A comparison with conventional laparoscopic surgery. J Cancer. 2024; 15(2): 533–538.
  32. Bizzarri N, Restaino S, Gueli Alletti S, et al. Sentinel lymph node detection in endometrial cancer with indocyanine green: laparoscopic versus robotic approach. Facts Views Vis Obgyn. 2021; 13(1): 15–25.
  33. Ignatov A, Mészáros J, Ivros S, et al. Oncologic Outcome of Robotic-Assisted and Laparoscopic Sentinel Node Biopsy in Endometrial Cancer. Cancers (Basel). 2023; 15(24).
  34. Cela V, Sergiampietri C, Rosa Obino ME, et al. Sentinel-lymph-node mapping with indocyanine green in robotic-assisted laparoscopic surgery for early endometrial cancer: a retrospective analysis. Facts Views Vis Obgyn. 2020; 11(4): 323–328.
  35. Lavoue V, Zeng X, Lau S, et al. Impact of robotics on the outcome of elderly patients with endometrial cancer. Gynecol Oncol. 2014; 133(3): 556–562.
  36. Wodzisławska A, Doniec J. Hospitalization time after laparotomy, laparoscopy and robotic procedures in patients with endometrial cancer. Lekarz Wojskowy. 2022; 100(2): 88–90.
  37. Pant A, Schink J, Lurain J. Robotic surgery compared with laparotomy for high-grade endometrial cancer. J Robot Surg. 2014; 8(2): 163–167.
  38. Sun H, Gao J, Jin Z, et al. Robotic single-site surgery versus laparoendoscopic single-site surgery in early-stage endometrial cancer: a case-control study. Wideochir Inne Tech Maloinwazyjne. 2021; 16(3): 597–603.
  39. Kadoch E, Brezinov Y, Levin G, et al. The impact of body mass index on robotic surgery outcomes in endometrial cancer. Gynecol Oncol. 2024; 185: 51–57.
  40. Drymiotou S, Dokmeci M, Chandrasekaran D, et al. Impact of minimally invasive surgery on surgical outcomes for obese women with endometrial cancer following robotic surgery introduction; a single centre study. Int J Med Robot. 2023 [Epub ahead of print]: e2559.
  41. Lindfors A, Heshar H, Adok C, et al. Long-term survival in obese patients after robotic or open surgery for endometrial cancer. Gynecol Oncol. 2020; 158(3): 673–680.
  42. Amirthanayagam A, Wood M, Teece L, et al. Impact of Patient Body Mass Index on Post-Operative Recovery from Robotic-Assisted Hysterectomy. Cancers (Basel). 2023; 15(17).
  43. Sofer A, Magnezi R, Eitan R, et al. Robotic vs. open surgery in obese women with low-grade endometrial cancer: comparison of costs and quality of life measures. Isr J Health Policy Res. 2020; 9(1): 60.
  44. Brar G, Xu S, Anwar M, et al. Robotic surgery: public perceptions and current misconceptions. J Robot Surg. 2024; 18(1): 84.
  45. Bizoń M, Olszewski M, Grabowska A, et al. Robotic surgery in endometrial cancer: first Polish experience. J Robot Surg. 2024; 18(1): 14.
  46. Sultan I, Bardi MF, Baatta AM, et al. Medical Students' Attitude Towards Robotic Surgery: A Cross-Sectional Survey. J Med Educ Curric Dev. 2022; 9: 23821205211066483.